1.Jacoby, GA. Extended-spectrum β-lactamases and other enzymes providing resistance to oxyimino-β-lactams. Infect Dis Clin North Am 1997;11:875–887.
2.Jacobson, KL, Cohen, SH, Inciardi, JF, et al. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I B-lactamase-producing organisms. Clin Infect Dis 1995;21:1107–1113.
3.Rice, LB, Eckstein, EC, DeVente, J, et al. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996;23:118–124.
4.Schiappa, DA, Hayden, MK, Matushek, MG, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 1996;174:529–536.
5.Knothe, H, Shah, P, Kremery, V, et al. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983;11:315–317.
6.Sirot, D, Sirot, J, Labia, R, et al. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel B-lactamase. J Antimicrob Chemother 1987;20:323–334.
7.Brun-Buisson, C, Legrand, P, Phillippon, A, et al. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987;2:302–306.
8.Rice, LB, Willey, SH, Papanicolaou, GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum B-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990;34:2200–2209.
9.Meyer, KS, Urban, C, Eagen, JA, et al. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353–358.
10.Itokazu, GS, Quinn, JP, Bell-Dixon, C, et al. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis 1996;23:779–784.
11.Lautenbach, E, Patel, JB, Bilker, WB, et al. Extended-spectrum B-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;15:1162–1171.
12.Paterson, DL, Ko, WC, Mohapatra, S, et al. Klebsiella pneumoniae bacteremia: impact of extended-spectrum B-lactamase (ESBL) production in a global study of 216 patients. Presented at the annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy; September 28-October 1, 1997; Toronto, Ontario, Canada.
13.Wiener, J, Quinn, JP, Bradford, PA, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999;281:517–523.
14.Lucet, JC, Chevret, S, Decre, D, et al. Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 1996;22:430–436.
15.Knaus, WA, Drapier, EA, Wagner, DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818–829.
16.National Committee for Clinical Laboratory Standards (NCCLS). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 5th ed. Approved standard. M7-A5. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000.
17.Thomson, KS, Sanders, CC. Detection of extended-spectrum beta-lacta-mases in members of the family enterobacteriaceae: comparison of the double-disk and three-dimensional tests. J Clin Microbiol 1992;36:1877–1882.
18.Livermore, DM, Williams, JD. B-lactams: mode of action and mechanisms of bacterial resistance. In: Lorian, V, ed. Antibiotics in Laboratory Medicine, 4th ed. Baltimore, MD: Williams and Wilkins; 1996.
19.Gautom, RK. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli 0157:H7 and other gram-negative organisms in 1 day. J Clin Microbiol 1997;35:2977–2980.
20.Kleinbaum, DG, Kupper, LL, Morgenstern, H. Epidemiologic Research: Principles and Quantitative Methods. New York: Van Nostrand Reinhold; 1982.
21.Mantel, N, Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719–748.
22.Hosmer, DW, Lemeshow, S. Applied Logistic Regression. New York: John Wiley & Sons; 1989.
23.Piroth, L, Aube, H, Doise, JM, et al. Spread of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: are β-lactamase inhibitors of therapeutic value? Clin Infect Dis 1998;27:76–80.
24.Pena, C, Pujol, M, Ardanuy, C, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1998;42:53–58.
25.DeChamps, C, Sauvant, MP, Chanal, C, et al. Prospective survey of colonization of infection caused by expanded-spectrum B-lactamase-producing members of the family enterobacteriaceae in an intensive care unit. J Clin Microbiol 1989;27:2887–2890.
26.Pena, C, Pujol, M, Ricart, A, et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum β-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect 1997;35:9–16.
27.Deere, D, Gachot, B, Lucet, JC, et al. Clinical and bactériologie epidemiology of extended-spectrum B-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit. Clin Infect Dis 1998;27:834–844.
28.Casewell, M, Philipps, I. Hands as route of transmission for Klebsiella species. Br Med J 1977;2:1315–1317.
29.D'Agata, E, Venkataraman, L, DeGirolami, P, et al. The molecular and clinical epidemiology of enterobacteriaceae producing extended-spectrum β-lactamase in a tertiary care hospital. J Hosp Infect 1998;36:279–285.
30.Lucet, JC, Fichelle, A, Decre, D, et al. Control of a prolonged outbreak of extended-spectrum B-lactamase-producing Enterobacteriaceae in a university hospital. Presented at the American Society for Microbiology 36th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; September 15-18, 1996; New Orleans, LA. Abstract no. J108.